New insider activity at Eli Lilly & Co ( (LLY) ) has taken place on November 5, 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Lilly Endowment Inc, a significant shareholder of Eli Lilly & Co, has recently sold 526 shares of the company’s stock. This transaction is valued at $479,033.
Spark’s Take on LLY Stock
According to Spark, TipRanks’ AI Analyst, LLY is a Outperform.
Eli Lilly & Co’s strong revenue growth and market share gains, highlighted in the earnings call, are significant positives. The technical indicators also suggest bullish momentum. However, high valuation and leverage, along with declining cash flow metrics, present potential risks. Overall, the stock is well-positioned but requires careful monitoring of financial leverage and cash flow management.
To see Spark’s full report on LLY stock, click here.
More about Eli Lilly & Co
YTD Price Performance: 18.17%
Average Trading Volume: 4,555,636
Technical Sentiment Signal: Buy
Current Market Cap: $857.3B